Sarah is an employee who works in a GMP environment for a life science company.

She wakes up one morning and has a bad cold but decides to go to work as usual.

As she handles raw materials in the manufacturing area she continually coughs and sneezes and carries on as normal.

Do you know what Sarah has done wrong here according to GMP regulations?

Detrimental Impact on Patient Safety and Product Quality

That’s right she has entered a manufacturing area with a potentially contagious disease which could have a detrimental impact on patient safety and product quality.
The regulations are very clear:

Employees involved in development, manufacturing, testing, release, and distribution must remember if they have open wounds, legions or contagious diseases they shall not enter manufacturing or storage areas until found fit to resume duties.

Adhere to Best Practice

Now that many workplaces are beginning to reopen after temporary closures due to Coronavirus (COVID-19), it’s important to remember that we must continue to adhere to best practices to reduce the spread of the virus—especially in pharmaceutical, medical device, and other good manufacturing practices (GMP) environments producing products for patients and the healthcare industry.

Remember, as our workplaces reopen, we must all be committed to reducing the spread of COVID-19.